Medical writing capacity pressure is fundamentally a talent development problem, not a technology problem, since hybrid ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, describes how manual eligibility screening and swivel-chair ...

In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patient cost barriers and site infrastructure ...

Patients don’t experience primary endpoints, so trials that stop at biomarkers and rigid rating scales risk declaring success ...

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the shift from narrow AI tools to a continuous learning ...

Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled ...

Regulation is not preventing continuous decision readiness. Increasingly, it is defining the conditions under which it can be ...

Syneos Health and Optum have announced a partnership to build what they describe as a more adaptive and connected model for ...

Javara CEO Jennifer Byrne talks about the requirements for embedding clinical trials directly into physician practices and why solving the “last mile” of trial participation means building ...

Kurt Mussina, CEO, Paradigm Clinical Research, describes his organization’s nine locations not as separately managed sites, ...

Mats Sundgren, Ashley Deis, Annie E. Almazar, Mathew Bush, Jose Galvez, Kathleen Hurtado, Lee Andrews, Nausheen Saleem, Anna Patruno, and Richard Yeatman | Authors | Applied Clinical Trials is the ...